Close

Adamas Pharmaceuticals (ADMS) PT Lowered to $23 at Piper Jaffray

March 5, 2019 3:15 AM EST
Get Alerts ADMS Hot Sheet
Price: $8.22 --0%

Rating Summary:
    4 Buy, 9 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE

Piper Jaffray analyst David Amsellem lowered the price target on Adamas Pharmaceuticals (NASDAQ: ADMS) to $23.00 (from $49.00) while maintaining a Overweight rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change

Related Entities

Piper Jaffray